Brazil’s JBS Posts Q1 77.6% Income Surge to $513M as Poultry Offsets U.S. Beef Woes

JBS SA (B3: JBSS3), the world’s largest meat processor, reported a 77.6% annual surge in net income to R$2.92 billion ($513 million) for Q1 2025, defying seasonal slumps and trade tensions through strategic geographic and protein diversification.

Revenue climbed 28% to R$114.1 billion ($20.02 billion), driven by domestic demand in Brazil and resilient export channels, according to filings and executive statements.

The São Paulo-based multinational’s adjusted EBITDA jumped 38.9% to R$8.93 billion ($1.57 billion), outperforming analyst forecasts by 1.7%. Margin expansion to 7.8% reflected operational efficiencies in poultry and pork divisions, offsetting challenges in North American beef markets.

CEO Gilberto Tomazoni credited the “global multi-protein platform” for insulating results, with Seara Brazil and Pilgrim’s Pride USA achieving record EBITDA margins of 19.8% and 14.8%, respectively.

Financial Engine

Strong cash generation of R$4.1 billion ($719 million) reduced leverage to 1.99x net debt/EBITDA, down from 3.66x in Q1 2024. Earnings per share more than doubled to R$1.32 ($0.23), while the proposed dual NYSE/B3 listing could unlock R$2.2 billion ($386 million) in shareholder returns pending minority approval.

Regional Realities

Brazilian operations thrived on cattle price advantages and value-added product innovation, but U.S. beef margins turned negative (-1.8% EBITDA) amid historic cattle shortages.

Australia capitalized on Asian export demand with 12% USD revenue growth. Currency shifts proved favorable-the real’s 18% depreciation against the dollar boosted BRL-denominated results.

Strategic Crossroads

Executives downplayed trade war impacts, noting only 23% of exports face tariff risks. The company’s integrated supply chain-spanning 76% domestic sales and 24% exports-buffered against localized disruptions. Goldman Sachs analysts flagged potential oversupply in U.S. poultry markets, but JBS emphasized contracted volumes through 2026.

Market Calculus

Shares closed flat at R$40.85 ($7.17) post-announcement, reflecting investor caution over U.S. cattle inventory pressures. The stock’s 12-month P/E of 14.3 lags behind Brazilian protein peers at 18.2, suggesting undervaluation of global diversification premiums.

Tomazoni concluded: “Our platform’s balance lets us redirect resources to high-margin segments when specific proteins or regions face headwinds.” With $1.57 billion quarterly EBITDA, JBS reinforces its capacity to navigate cyclical volatility through scale and operational agility.